Positive results from completed Phase 2 study of mavorixafor in chronic neutropenia (CN) announced todayPivotal Phase 3 trial of mavorixafor in ...

Key strategic advancements include the ongoing review of nirogacestat by the European Medicines Agency and promising data from clinical trials for mirdametinib, indicating potential for future market ...

In the past decade, CPP has achieved significant success, including seven regulatory milestones, including the first ...

The Official Journal of the European Union is the official publication (gazette) for EU legal acts, other acts and official information from EU institutions, bodies, offices and agencies. It is ...